PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
August 19, 1997Circulation230 citations

Sustained Hemodynamic Efficacy of Therapy Tailored to Reduce Filling Pressures in Survivors With Advanced Heart Failure

View Full Paper
ASAnthony SteimleLSLynne W. StevensonCCCatherine Chelimsky-Fallick

Structured PICO

Does therapy tailored to early hemodynamic response improve long-term hemodynamic parameters in survivors with advanced heart failure?

P
Population
n=25 patients with advanced heart failure referred for cardiac transplantation with initially severe hemodynamic decompensation who survived without transplantation.
I
Intervention
Therapy tailored to early hemodynamic response (net diuresis, increased ACE inhibitor doses, frequent addition of nitrates) for 8+/-6 months.
O
Outcome
Hemodynamic parameters including pulmonary wedge pressure, systemic vascular resistance, and stroke volume at 8+/-6 months.surrogate

In survivors of advanced heart failure, chronic therapy tailored to early hemodynamic response sustains near-normal filling pressures and progressively increases stroke volume over 8 months.

Limitations

  • Study design did not control for amiodarone
  • Contributions of the monitored hemodynamic approach, increased vasodilator doses, and comprehensive outpatient management have not yet been established

Abstract

BACKGROUND: During therapy to relieve congestion in advanced heart failure, cardiac filling pressures can frequently be reduced to near-normal levels with improved cardiac output. It is not known whether the early hemodynamic improvement and drug response can be maintained long term. METHODS AND RESULTS: After referral for cardiac transplantation with initially severe hemodynamic decompensation, 25 patients survived without transplantation to undergo hemodynamic reassessment after 8+/-6 months of treatment tailored to early hemodynamic response. Initial changes included net diuresis, increased ACE inhibitor doses, and frequent addition of nitrates. After 8 months of therapy, early reductions were sustained for pulmonary wedge pressure (24+/-9 to 15+/-5 mm Hg early; 12+/-6 mm Hg late) and systemic vascular resistance (1651+/-369 to 1207+/-281 dynes x s(-1) x cm(-5) early; 1003+/-193 dynes x s(-1) x cm(-5) late). Acute response to doses persisted at reevaluation. Sustained reduction in filling pressures was accompanied by a progressive increase in stroke volume (42+/-10 to 56+/-13 mL early; 79+/-20 mL late), improved functional class, and freedom from resting symptoms. Study design did not control for amiodarone, which was initiated for arrhythmias in 12 patients and associated with greater improvement in cardiac index (1.8 to 3.2 L min(-1) x m(-2) late on amiodarone versus 2.0 to 2.6 L x min(-1) x m(-2), P<.05). CONCLUSIONS: During chronic therapy tailored to early hemodynamic response in advanced heart failure, acute vasodilator response persists, and near-normal filling pressures can be maintained in patients who survive without transplantation. Stroke volumes at low filling pressures increase further over time. Chronic hemodynamic improvement was accompanied by symptomatic improvement, but the contributions of the monitored hemodynamic approach, increased vasodilator doses, and comprehensive outpatient management have not yet been established.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Steimle et al. (1997) studied this question.

synapsesocial.com/papers/69fab3eb79c9fe70ce3f56cfhttps://doi.org/10.1161/01.cir.96.4.1165
Ask AI
Helpful
Bookmark
Share
View Full Paper